A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severe Active Crohn’s Disease

  • Sandhu, Manjeet (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date2/12/25 → 1/12/30

Clinical Trial Phase

  • Phase II
  • Phase III (a & b)
  • External Sponsor